Verana Health is a health technology company dedicated to assembling the largest clinical databases in medicine to empower physicians and accelerate research for patients.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
01/14/2022 | Series E | $150MM | $xx.xx | $531.55MM | Johnson & Johnson Innovation, Novo Growth, GV, Casdin Capital, Brook Byers, Merck Global Health Innovation Fund, THVC, Breyer Capital | |
Price per Share
$xx.xx
Shares Outstanding
71,442,179
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Johnson & Johnson Innovation, Novo Growth, GV, Casdin Capital, Brook Byers, Merck Global Health Innovation Fund, THVC, Breyer Capital
|
||||||
02/05/2020 | Series D | $100MM | $xx.xx | $256.86MM | Google Ventures, Bain Capital Ventures, Casdin Capital, Define Ventures | |
Price per Share
$xx.xx
Shares Outstanding
50,027,508
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Google Ventures, Bain Capital Ventures, Casdin Capital, Define Ventures
|
||||||
07/31/2018 | Series C | $32.98MM | $xx.xx | $49.44MM | Google Ventures, Biomatics Capital, Brook Byers, Perkins, Caufield & Byers, GE Ventures, Lagunita Biosciences | |
Price per Share
$xx.xx
Shares Outstanding
41,223,930
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Google Ventures, Biomatics Capital, Brook Byers, Perkins, Caufield & Byers, GE Ventures, Lagunita Biosciences
|
||||||
02/09/2015 | Series B | $14.05MM | $xx.xx | $21.85MM | Biosys Capital, Waycross Ventures, GE Ventures, Lagunita LLC | |
Price per Share
$xx.xx
Shares Outstanding
4,705,415
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.9x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Biosys Capital, Waycross Ventures, GE Ventures, Lagunita LLC
|
||||||
01/01/2013 | Series A | $920,982 | $xx.xx | $4.6MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
418,628
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.7x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|